美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 48 条
共 3 页，当前第 2 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| TACROLIMUS |
200744 |
002 |
ANDA |
TACROLIMUS |
OINTMENT;TOPICAL |
0.1% |
No
|
No
|
2014/09/09
|
2014/09/09
|
FOUGERA PHARMS INC |
Prescription |
| TACROLIMUS |
203900 |
001 |
ANDA |
TACROLIMUS |
INJECTABLE;INJECTION |
EQ 5MG BASE/ML |
No
|
No
|
2017/08/25
|
2017/08/25
|
HOSPIRA |
Discontinued |
| TACROLIMUS |
206651 |
001 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 0.5MG BASE |
No
|
No
|
2017/11/30
|
2017/11/30
|
BELCHER |
Prescription |
| TACROLIMUS |
206651 |
002 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 1MG BASE |
No
|
No
|
2017/11/30
|
2017/11/30
|
BELCHER |
Prescription |
| TACROLIMUS |
206651 |
003 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 5MG BASE |
No
|
No
|
2017/11/30
|
2017/11/30
|
BELCHER |
Prescription |
| TACROLIMUS |
210393 |
001 |
ANDA |
TACROLIMUS |
OINTMENT;TOPICAL |
0.1% |
No
|
No
|
2018/04/16
|
2018/04/16
|
GLENMARK PHARMS LTD |
Prescription |
| TACROLIMUS |
210393 |
002 |
ANDA |
TACROLIMUS |
OINTMENT;TOPICAL |
0.03% |
No
|
No
|
2018/04/16
|
2023/08/16
|
GLENMARK PHARMS LTD |
Prescription |
| TACROLIMUS |
211688 |
001 |
ANDA |
TACROLIMUS |
OINTMENT;TOPICAL |
0.03% |
No
|
No
|
2019/01/31
|
2019/01/31
|
ACCORD HLTHCARE |
Prescription |
| TACROLIMUS |
211688 |
002 |
ANDA |
TACROLIMUS |
OINTMENT;TOPICAL |
0.1% |
No
|
No
|
2019/01/31
|
2019/01/31
|
ACCORD HLTHCARE |
Prescription |
| TACROLIMUS |
206662 |
001 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 0.5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
GLENMARK PHARMS LTD |
Prescription |
| TACROLIMUS |
206662 |
002 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 1MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
GLENMARK PHARMS LTD |
Prescription |
| TACROLIMUS |
206662 |
003 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
GLENMARK PHARMS LTD |
Prescription |
| TACROLIMUS |
212297 |
001 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 0.5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
BIOCON PHARMA |
Prescription |
| TACROLIMUS |
212297 |
002 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 1MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
BIOCON PHARMA |
Prescription |
| TACROLIMUS |
212297 |
003 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
BIOCON PHARMA |
Prescription |
| TACROLIMUS |
213112 |
001 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 0.5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
CONCORD BIOTECH LTD |
Discontinued |
| TACROLIMUS |
213112 |
002 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 1MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
CONCORD BIOTECH LTD |
Prescription |
| TACROLIMUS |
213112 |
003 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 5MG BASE |
No
|
No
|
2020/11/10
|
2020/11/10
|
CONCORD BIOTECH LTD |
Prescription |
| TACROLIMUS |
203740 |
001 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 0.5MG BASE |
No
|
No
|
2020/11/12
|
2020/11/12
|
ALKEM LABS LTD |
Prescription |
| TACROLIMUS |
203740 |
002 |
ANDA |
TACROLIMUS |
CAPSULE;ORAL |
EQ 1MG BASE |
No
|
No
|
2020/11/12
|
2020/11/12
|
ALKEM LABS LTD |
Prescription |